Heidelberg Engineering announced FDA clearance of the SPECTRALIS Flex Module. This multimodal, diagnostic imaging-only platform is designed for imaging the posterior segment of pediatric and adult patients in a supine position, the company said in a press release. 

The Flex Module mounts the SPECTRALIS to a movable stand with an articulated adjustable arm, offering flexibility that extends imaging capabilities to various positions and acquisition environments. This is particularly beneficial for patients who cannot be imaged with traditional tabletop optical coherence tomography (OCT) devices, the company said. 

Similar to the traditional tabletop SPECTRALIS device, the Flex Module offers various imaging-only modalities, including high-resolution OCT, OCT angiography (OCTA), fluorescein angiography, indocyanine-green angiography, blue laser autofluorescence, MultiColor, and both widefield and ultra-widefield imaging. According to the company, this multimodal imaging approach helps ensure convenient examinations for all patients.

The SPECTRALIS Flex Module will be showcased at the Heidelberg Engineering exhibition stand (#4444) during the American Academy of Ophthalmology Congress in Chicago, Oct. 19-21.